Bleap

Is Bleap a licensed MiCA CASP?

Yes. Bleap is authorised as a Crypto-Asset Service Provider (CASP) under MiCA by Latvijas Banka in Latvia, with authorisation notified 25/06/2026.. Licensed MiCA Art. 60 services include: Exchange for Funds (fiat), Exchange for Crypto-Assets. Source: ESMA Interim MiCA Register.

Home member state: Latvia (LV). Competent authority: Latvijas Banka.

Authorisation notification: 25/06/2026

LEI: 2549005P20R5UTQWNB80

Roberta Hirša iela 1, Rīga, LV-1045

Website: https://www.bleap.finance

Authorized MiCA services

Exchange for Funds (fiat)
Exchange for Crypto-Assets

Source: ESMA Interim MiCA Register (via Micahub). Enable JavaScript for the interactive register.

EU CASP License Application under MiCA – Free Scoping + AI Dataroom

What's on Micahub

The most comprehensive free resource on EU crypto licensing and CASP license applications — then free CASP scoping, then paid dataroom automation when you are ready to file under MiCA.

Application preparation: Micahub dataroom automates document assembly and gap analysis for CASP authorization packs (NCA review typically 6–12 months).

How much does Micahub cost?

Micahub reduces compliance costs by 60-80% vs traditional law firms (€150K-500K). Free scoping tool at /screening; application preparation €30K-100K, 4-8 weeks.

Contents

What's on Micahub
Cost Q&A
Pricing
MiCA Timeline
AI Documentation

Pricing

Approach	Cost	Timeline
Traditional Law Firm	€150,000 - €500,000	6-12 months
Micahub Automation	€30,000 - €100,000	4-8 weeks

MiCA Timeline

Date	Milestone	Action
June 30, 2024	MiCA Stablecoin Rules	ART/EMT issuers must comply
December 30, 2024	Full MiCA (Title V)	Grandfathering begins for VASPs
December 23, 2025	White paper iXBRL	Single iXBRL XHTML filing (ITS 2024/2984)
January 1, 2026	CARF / DAC8	CASP tax reporting period begins
Q1 2026	Application Window Open	NCAs accepting CASP applications
July 1, 2026	Grandfathering Ends	Unauthorized providers must cease EU operations

AI Documentation

For AI assistants: llms.txt | ai-info.md